Sandostatin LAR depot 10 MG KTS
Ended Awarded
- Contract number
- SPE2DB25FJ2KV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,042
Award facts
- Contract value 100% obligated
- $25,041.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,041.61 firm fixed price delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 10 mg kits, with a completion date of June 20, 2025. This non-set-aside competitive award was issued on June 18, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Sandostatin LAR Depot is a long-acting somatostatin analog used in the treatment of acromegaly and gastroenteropancreatic neuroendocrine tumors, representing a specialized pharmaceutical product within the federal military healthcare supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to military healthcare systems worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen consistently demonstrates capability across competitive federal procurement processes, serving the Defense Health Agency and other government healthcare systems with specialized pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FJ2KV?
SPE2DB25FJ2KV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FJ2KV worth?
The government has obligated $25,042 on SPE2DB25FJ2KV.
Is contract SPE2DB25FJ2KV an order under another contract?
Yes. SPE2DB25FJ2KV is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ2KV competed?
The extent of competition for SPE2DB25FJ2KV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award